This is an old revision of this page, as edited by 200.120.206.115 (talk) at 01:36, 29 December 2011 (poor writing and inappropriate medical advice removed). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 01:36, 29 December 2011 by 200.120.206.115 (talk) (poor writing and inappropriate medical advice removed)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compound| Clinical data | |
|---|---|
| Routes of administration | Injection into intervertebral disc |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| (what is this?) (verify) | |
Chymopapain (trand name Chymodiactin) is a proteolytic enzyme isolated from the latex of papaya (Carica papaya). It is a medication used to treat herniated lower lumbar discs in the spine. Chymopapain injections are normally given under local, rather than general, anaesthesia. The dose for a single intervertebral disc is 2 to 4 nanokatals, with a maximum dose per patient of 8 nanokatals.
The sale and distribution of chymopapain was discontinued in the United States on January 27, 2003.
Side effects
Serious side effects from the use of chymopapain include anaphylaxis, paralysis of the legs, or death.
See also
References
- Chymopapain Injection from MedicineNet
- http://www.mayoclinic.com/health/drug-information/DR600373
- http://www.mayoclinic.com/health/drug-information/DR600373
External links
- The MEROPS online database for peptidases and their inhibitors: C01.002
- Data sheet for Papain from BIOZYM
 | This drug article relating to the musculoskeletal system is a stub. You can help Misplaced Pages by expanding it. |
 | This enzyme-related article is a stub. You can help Misplaced Pages by expanding it. |